학술논문

Combined Hepatocholangiocarcinoma Associated with Humoral Hypercalcemia of Malignancy and Chronic Inflammatory Demyelinating Polyneuropathy
Case Report
Document Type
Academic Journal
Source
Case Reports in Oncological Medicine. July 2019
Subject
Diagnosis
Health aspects
Denosumab -- Health aspects
Parathyroid hormones -- Health aspects
Liver cancer -- Diagnosis -- Health aspects
Intravenous immunoglobulins -- Health aspects
Hypercalcemia -- Diagnosis -- Health aspects
Nervous system diseases -- Diagnosis -- Health aspects
Polyneuropathies -- Diagnosis -- Health aspects
Language
English
ISSN
2090-6706
Abstract
1. Introduction Paraneoplastic syndromes are often a diagnostic challenge to doctors and may present as any of a wide variety of clinical syndromes resulting from the release of self-peptides or [...]
Paraneoplastic syndromes are often a diagnostic challenge to doctors and may have a heterogeneous presentation, including humoral hypercalcemia of malignancy (HHM), most commonly caused by squamous cell cancer and renal, ovarian, endometrial, and breast cancer. Chronic inflammatory demyelinating polyneuropathy (CIDP) has been described in patients affected by several types of cancer, especially hematologic malignancies, and a possible paraneoplastic pathogenesis of this neurological disease has been suggested. This report describes a 56-year-old man with a history of CIDP diagnosed 3 months earlier and persistently elevated aminotransferases for 18 months who was admitted to our internal medicine unit with abdominal pain, fatigue, and severe hypercalcemia with low serum intact parathyroid hormone. Parathyroid hormone-related protein (PTH-rP) was markedly high. Liver imaging showed a large hepatic mass in the right lobe, and percutaneous ultrasound-guided biopsy revealed histopathological findings consistent with a combined hepatocholangiocarcinoma (CHCC). We supposed that both HHM and CIDP could represent a paraneoplastic manifestation of CHCC.